Novel Antithrombotic Agents in Ischemic Cardiovascular Disease: Progress in the Search for the Optimal Treatment
Ischemic cardiovascular diseases have a high incidence and high mortality worldwide. Therapeutic advances in the last decades have reduced cardiovascular mortality, with antithrombotic therapy being the cornerstone of medical treatment. Yet, currently used antithrombotic agents carry an inherent ris...
Main Authors: | Ignacio Barriuso, Fernando Worner, Gemma Vilahur |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Journal of Cardiovascular Development and Disease |
Subjects: | |
Online Access: | https://www.mdpi.com/2308-3425/9/11/397 |
Similar Items
-
Current Guidelines on Antithrombotic Management in Patients Undergoing Gastrointestinal Endoscopy
by: Muhammad Begawan Bestari, et al.
Published: (2019-05-01) -
Does Antithrombotic Therapy Affect Outcomes in Major Trauma Patients? A Retrospective Cohort Study from a Tertiary Trauma Centre
by: Stefano Sartini, et al.
Published: (2022-09-01) -
Gastrointestinal Endoscopy in Patients Receiving Antithrombotic Therapy
by: Supriadi Supriadi, et al.
Published: (2021-09-01) -
Outcomes of Endoscopic Ultrasound-Guided Biliary Drainage in Patients Undergoing Antithrombotic Therapy
by: Nozomi Okuno, et al.
Published: (2021-07-01) -
Antithrombotics prescription and adherence among stroke survivors: A systematic review and meta‐analysis
by: Min Yang, et al.
Published: (2022-10-01)